Product correctly added to cart.

discount label
Salbutamol-d3
View 3D

Biosynth logo

Salbutamol-d3

CAS: 1219798-60-3

Ref. 3D-FS174998

5mgTo inquire
10mgTo inquire
Estimated delivery in United States, on Tuesday 2 Jul 2024

Product Information

Name:
Salbutamol-d3
Controlled Product
Description:

Salbutamol-d3 is a radiopharmaceutical used in the diagnosis of chronic bronchitis. It is administered orally, intravenously, or by inhalation and is converted to salbutamol-d3 in vivo. Salbutamol-d3 has been shown to have anabolic properties, which may be due to its ability to bind with adrenergic receptors. This drug also has pharmacokinetic properties that are dependent on dose and route of administration. For example, it has a longer half-life when administered orally as opposed to intravenously. Salbutamol-d3 can also be used for wastewater treatment because it binds with organic matter and prevents the formation of precipitates during sewage treatment processes. Radiochemical purity can be determined using analytical methods such as gas chromatography/mass spectrometry (GC/MS) or liquid chromatography/mass spectrometry (LC/MS). The chemical structures of this drug are similar to other drugs that are

Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
242.33 g/mol
Formula:
C13H18D3NO3
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-FS174998 Salbutamol-d3

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".